Cirrhosis Clinical Trials in New York, New York

4 studies are recruiting for cirrhosis in New York, New York right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Droxidopa to Increase Mean Arterial Pressure in Decompensated Cirrhosis Patients With Acute Kidney Injury

    This study tests whether a medication called droxidopa can help improve blood flow to the kidneys in people with liver cirrhosis who develop kidney problems while in the hospital. When someone with cirrhosis experiences kidney injury, having better blood pressure can help their kidneys recover. Dro…

    Stage
    Phase 2
    Ages
    18 to 70
    Site
    Columbia University Irving Medical Center, New York, New York
    Run by
    Giuseppe Cullaro, MD

    See if you can join NCT06937307 on ClinicalTrials.gov

  2. Affect of Melatonin on Sleep and Cognition in Cirrhosis

    The goal of this clinical trial is to learn the affect of melatonin on sleep, cognitive function, and quality of life (QoL) in patients with cirrhosis and a complication called hepatic encephalopathy (HE). The main questions this study aims to answer are: * Does taking melatonin increase REM sleep,…

    Stage
    Not phased
    Ages
    18 and older
    Site
    NewYork-Presbyterian/Weill Cornell Medical Center, New York, New York
    Run by
    Weill Medical College of Cornell University

    See if you can join NCT07046429 on ClinicalTrials.gov

  3. Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI

    The study is a randomized trial of two different screening methods for early detection of liver cancer in patients with cirrhosis of the liver. The goal of PREMIUM is to compare an abbreviated version of the diagnostic gold standard for HCC (aMRI) +AFP to the standard-of-care screening (US+AFP) in …

    Stage
    Not phased
    Ages
    18 to 75
    Site
    VA NY Harbor Healthcare System, New York, NY, New York, New York
    Locations
    34 in total
    Run by
    VA Office of Research and Development

    See if you can join NCT05486572 on ClinicalTrials.gov

  4. Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States

    This is a double-blind, phase 2 study to evaluate safety and efficacy of rosuvastatin in comparison to placebo after 2 years in patients with compensated cirrhosis.

    Stage
    Phase 2
    Ages
    18 to 75
    Site
    New York Presbyterian/Weill Cornell, New York, New York
    Locations
    13 in total
    Run by
    National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

    See if you can join NCT05832229 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.